• Register
  • Login
  • Subscribe
  • Contact Us

Latest Biosimilar Tenders in Greatbritain 2025

GreatbritainTenders brings you the latest and most relevant Biosimilar tenders in Greatbritain, sourced directly from reliable government portals, purchaser websites, and leading procurement publications. Whether you're a supplier, contractor, or manufacturer, we ensure you stay informed about ongoing bidding opportunities without missing a beat.

Our platform is regularly updated with tenders related to Biosimilar and other keywords tenders. Each listing includes key details such as tender reference numbers, submission deadlines, and purchaser information helping you make informed bidding decisions quickly and confidently.

By subscribing to GreatbritainTenders, users gain unlimited access to public procurement notices related to Biosimilar. Our tools also offer category-based filtering, email alerts, and quick tender downloads, making your bidding process faster and more efficient. Stay ahead of the competition and grow your business by exploring verified tenders from both government and private entities across Greatbritain.

Np49425 Generic and Biosimilar Transition Medicines

GBT Ref No.:  124863553

Deadline:  22 Sep 2025

Branded and Biosimilar Ophthalmology

GBT Ref No.:  124049151

Deadline:  05 Sep 2025

Np49425 Generic and Biosimilar Transition Medicines

GBT Ref No.:  123977766

Deadline:  19 Sep 2025

Np49425 Generic and Biosimilar Transition Medicines

GBT Ref No.:  123961688

Deadline:  05 Aug 2026

Np39724 Generic and Biosimilar Cancer Medicines

GBT Ref No.:  105346597

Deadline:  02 Sep 2024

Np39724 Generic and Biosimilar Cancer Medicines

GBT Ref No.:  105194448

Deadline:  02 Sep 2024

Future Notice: Licensed Bulk Medicines

GBT Ref No.:  84191692

Deadline:  10 Jun 2024

Clinical Recombinant Biological Products Framework (R&D)

GBT Ref No.:  80384261

Deadline:  20 Apr 2023

Clinical Recombinant Biological Products Framework

GBT Ref No.:  80384228

Deadline:  20 Apr 2023

Nhs National Proprietary Pharmaceuticals - Eculizumab Biosimilar

GBT Ref No.:  74458753

Deadline:  01 May 2023

  Chat with us